Mytrex Health Technologies Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Fred Yang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 12.6yrs |
Recent management updates
Recent updates
The Trend Of High Returns At Mytrex Health Technologies (GTSM:4431) Has Us Very Interested
Apr 01
Could The Market Be Wrong About Mytrex Health Technologies, Inc. (GTSM:4431) Given Its Attractive Financial Prospects?
Feb 07
Shareholders of Mytrex Health Technologies (GTSM:4431) Must Be Delighted With Their 438% Total Return
Jan 04Should You Rely On Mytrex Health Technologies's (GTSM:4431) Earnings Growth?
Dec 07CEO
Fred Yang (56 yo)
11.1yrs
Tenure
Mr. Hung-Jen Yang, also known as Fred, was Chairman of Board of ShareHope Medicine Co. Ltd. until June 25, 2024. He was Chairman & CEO of ShareHope Medicine Co. Ltd.from January 31, 2020. He was CEO & Pre...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| General Manager and Director | 13.1yrs | NT$120.00k | no data | |
| Chairman & CEO | 11.1yrs | no data | no data | |
| Director | 13.1yrs | no data | no data | |
| Independent Director | 13.1yrs | no data | no data | |
| Director | 13.1yrs | no data | no data | |
| Independent Director | 13.1yrs | no data | no data | |
| Independent Director | 12.1yrs | no data | no data | |
| Supervisor | 12.1yrs | NT$96.00k | no data | |
| Supervisor | 12.1yrs | NT$69.00k | no data | |
| Supervisor | 10.9yrs | no data | no data |
12.6yrs
Average Tenure
Experienced Board: 4431's board of directors are seasoned and experienced ( 12.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/18 04:50 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mytrex Health Technologies, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|